3 Magnificent Stocks Retirees Can Buy and Hold Forever [Yahoo! Finance]
Gilead Sciences, Inc. (GILD)
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.gilead.com
Company Research
Source: Yahoo! Finance
Three Motley Fool contributors think they've found magnificent stocks retirees can buy and hold forever. Here's why they picked AbbVie (NYSE: ABBV) Gilead Sciences (NASDAQ: GILD) , and Johnson & Johnson (NYSE: JNJ) A Dividend King poised for growth Keith Speights (AbbVie) : There's arguably no group of stocks better suited for retirees than the Dividend Kings. These stocks have increased their dividends for at least 50 consecutive years. AbbVie is a member of dividend royalty thanks to its track record of 52 years in a row of dividend hikes. Some Dividend Kings offer paltry dividend yields, but not AbbVie. The big drugmaker's dividend payout has soared nearly 45% over the last five years, with its yield currently hovering around 3.7%. Even better, AbbVie is poised for solid growth. That might be surprising considering that sales are sinking for the company's top-selling drug, Humira, in the face of biosimilar competition. However, AbbVie has a strong stable of newer products
Show less
Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GILD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
News
- NACD Announces 10 Finalists for the 2024 DE&I Awards [Yahoo! Finance]Yahoo! Finance
- Should You Be Concerned About Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE? [Yahoo! Finance]Yahoo! Finance
- Gilead Sciences, Inc. (NASDAQ: GILD) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $74.00 price target on the stock.MarketBeat
- Should You Hold Gilead Sciences (GILD)? [Yahoo! Finance]Yahoo! Finance
- NEW DATA SUPPORT THE USE OF BICTEGRAVIR TABLET REGIMEN TO TREAT PEOPLE WITH HIV AND INDIVIDUALS WITH HIV/HBV-COINFECTION IN ASIA [Yahoo! Finance]Yahoo! Finance
GILD
Earnings
- 4/25/24 - Beat
GILD
Sec Filings
- 7/1/24 - Form 4
- 7/1/24 - Form 144
- 6/11/24 - Form 4
- GILD's page on the SEC website